Not applicableUnknownNCT04523467
What this trial is testing
Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma
Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 320